Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Rangering i aksjer #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Aksjekurs
$1.51
Sist synkronisert: 2024-08-26
Markedsverdi
$1.12M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Agile Therapeutics, Inc. (AGRX)

Kategori

Inntekter for Agile Therapeutics, Inc. (AGRX)
Inntekter i Jun 2024 TTM: $-15.86M
Ifølge Agile Therapeutics, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat $-15.86M. I 2022 hadde selskapet et resultat på $-30.09M, en økning sammenlignet med resultatet i 2021, som var $-74.89M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Agile Therapeutics, Inc. fra 2012 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $-15.86M 9.62%
2023 $-14.47M -51.92%
2022 $-30.09M -59.83%
2021 $-74.89M 44.44%
2020 $-51.85M 178.69%
2019 $-18.61M -8.15%
2018 $-20.26M -28.43%
2017 $-28.30M -11.04%
2016 $-31.82M -12.37%
2015 $-36.31M 84.02%
2014 $-19.73M 37.77%
2013 $-14.32M -38.43%
2012 $-23.26M 0.00%
Inntekter for lignende selskaper eller konkurrenter